Table 3.
Laboratory and imaging characteristics.
| Case 1 (M, 5 years, BMI > 95th pc) | Case 2 (M, 5.5 years, BMI 25th–50th pc) | Case 3 (F, 6.9 years, BMI > 95th pc) | Case 4 (M, 8.9 years, BMI > 95th pc) | Case 5 (F, 6.8 years, BMI 90th–95th pc) | Median (range) | Normal values | |
|---|---|---|---|---|---|---|---|
| CRP (mg/L) | 161.4 | 131 | 386.7 | 191.4 | 225.2 | 131–386.7 | < 2 |
| PCT (ng/mL) | 9.2 | 86.4 | 19.8 | 2.4 | > 100 | 2.4–> 100 | < 0.5 |
| ERS (mm/h) | 38 | 49 | 40 | 36 | 37 | 36–49 | |
| WBC (/μL) first sample | 5710 | 19,060 | 9080 | 8350 | 7620 | 5710–19,060 | 6000–18000 |
| Lymphocytes first sample (/μL) | 760 | 1820 | 430 | 460 | 580 | 430–1820 | 1800–13500 |
| D-dimer (ng/mL) | 2384 | 2662 | 2233 | 1922 | 3081 | 1922–3081 | 0–500 |
| Fibrinogen (mg/dL) | 587 | 630 | 1038 | 656 | 525 | 525–1038 | 200–450 |
| Troponin (ng/L) | 60.5 | 48.3 | 70 | 34.3 | 105.2 | 34.3–105.2 | < 19.8 |
| NT-proBNP (pg/mL) | 20,400 | 9500 | 20,200 | 2480 | 26,000 | 2480–26,000 | < 300 |
| IL-6 (pg/mL) | 470.1 | 15.1 | 186.5 | 74.4 | 692.5 | 15.1–692.5 | < 6.4 |
| Anti-SARS-CoV-2 IgG (AU/mL) | 190.1 | 158.8 | 98 | 129 | 68.3 | 68.3–190.1 | < 8 |
| Anti-SARS-CoV-2 IgM (AU/mL) | 32.7 | 5.1 | 4.7 | 4.43 | 0.43 | 0.43–32.7 | < 8 |
| Chest X-ray | Increased reticular pattern in the perihilar and parahilar regions | Some consolidations in the parahilar region | Left lower parahilar bronchovascular crowding with subtle atelectasis | Consolidation in the right perihilar and parahilar region | Increased reticular pattern in the perihilar and parahilar regions | — | — |
| Echocardiogram (first evaluation) | EF < 50% | Normal | Mild mitral and tricuspid insufficiency; minimal pericardial effusion | Mild mitral and tricuspid insufficiency; minimal pericardial effusion | EF < 55%, mild mitral insufficiency, moderate tricuspid insufficiency | — | — |
| Echocardiogram (follow-up) | Normal | Normal | Normal | Normal | Normal | — | — |
| Exploratory laparoscopy | + | − | − | − | − | − | − |
| Treatment | |||||||
| IGIV | + | + | + | + | + | ||
| Corticosteroids | + | + | + | + | + | ||
| Aspirin | − | + | − | − | + | ||
| Heparin | + | − | − | − | + | ||
| Antibiotics | + | + | + | + | + | ||
| Diuretics | − | − | − | − | + | ||
| Oxygen | − | − | − | − | + | ||
| TPN | − | − | − | − | + |